{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:22:41Z","timestamp":1790050961735,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["G2016013"],"award-info":[{"award-number":["G2016013"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872743"],"award-info":[{"award-number":["81872743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102080450"],"award-info":[{"award-number":["202102080450"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bcp.2022.115326","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T16:12:04Z","timestamp":1667059924000},"page":"115326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Bortezomib inhibits NLRP3 inflammasome activation and NF-\u03baB pathway to reduce psoriatic inflammation"],"prefix":"10.1016","volume":"206","author":[{"given":"Xiuhui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bcp.2022.115326_b0005","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2022.115326_b0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Bio."},{"issue":"9","key":"10.1016\/j.bcp.2022.115326_b0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.bcp.2022.115326_b0020","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging Activators and Regulators of Inflammasomes and Pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115326_b0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.bcp.2022.115326_b0030","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.bcp.2022.115326_b0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115326_b0040","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbt.2009.03.012","article-title":"How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerations","volume":"25","author":"Jahn","year":"2009","journal-title":"New Biotechnol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-013-1327-8","article-title":"Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid","volume":"305","author":"Balato","year":"2013","journal-title":"Arch. Dermatol. Res."},{"issue":"12","key":"10.1016\/j.bcp.2022.115326_b0050","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility","volume":"21","author":"Carlstr\u00f6m","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","article-title":"Enhanced Inflammasome Activity in Patients with Psoriasis Promotes Systemic Inflammation","volume":"141","author":"Verma","year":"2021","journal-title":"J, Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115326_b0060","first-page":"1086","article-title":"Silencing of miR-155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation","volume":"42","author":"Luo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2022.115326_b0065","series-title":"Adv","first-page":"55","article-title":"Chapter Three - The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases","author":"Jiang","year":"2020"},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminhematol.2012.04.004","article-title":"Proteasome Inhibitors as Immunosuppressants: Biological Rationale and Clinical Experience","volume":"49","author":"Moran","year":"2012","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115326_b0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1124\/mol.108.049114","article-title":"Dynamic effect of bortezomib on nuclear factor-kappaB activity and gene expression in tumor cells","volume":"74","author":"Sung","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115326_b0080","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1002\/art.27690","article-title":"The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats","volume":"62","author":"Yannaki","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.bcp.2022.115326_b0085","doi-asserted-by":"crossref","first-page":"e64262","DOI":"10.1371\/journal.pone.0064262","article-title":"The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.bcp.2022.115326_b0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/gut.2009.203554","article-title":"Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis","volume":"59","author":"Schmidt","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3349\/ymj.2015.56.1.112","article-title":"The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture","volume":"56","author":"Han","year":"2015","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bcp.2022.115326_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.561306","article-title":"Ubc9 Attenuates Myocardial Ischemic Injury Through Accelerating Autophagic Flux","volume":"11","author":"Xiao","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0105","doi-asserted-by":"crossref","first-page":"33710","DOI":"10.1038\/srep33710","article-title":"The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers","volume":"6","author":"Alshareef","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2022.115326_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2020.03.007","article-title":"Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation","volume":"152","author":"Deng","year":"2020","journal-title":"Free Radical Biol. Med."},{"issue":"7","key":"10.1016\/j.bcp.2022.115326_b0115","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"issue":"19","key":"10.1016\/j.bcp.2022.115326_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197228","article-title":"Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis","volume":"21","author":"Fenix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0125","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41598-020-60050-1","article-title":"Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0130","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.15306","article-title":"DGT, a novel heterocyclic diterpenoid, effectively suppresses psoriasis via inhibition of STAT3 phosphorylation","volume":"178","author":"Bian","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115326_b0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/bjd.17852","article-title":"Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis","volume":"181","author":"Shi","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.bcp.2022.115326_b0140","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1074\/jbc.RA117.000667","article-title":"Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-kB activity and increases drug resistance in multiple myeloma","volume":"293","author":"Huynh","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.bcp.2022.115326_b0145","doi-asserted-by":"crossref","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2022.115326_b0150","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2011.09.020","article-title":"Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation","volume":"314","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.bcp.2022.115326_b0160","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1038\/s41388-019-0675-z","article-title":"Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0165","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","article-title":"N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis","volume":"11","author":"Karmakar","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2022.115326_b0170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115326_b0175","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2022.115326_b0180","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1096\/fj.201902938RR","article-title":"Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC","volume":"34","author":"Su\u0161jan","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2022.115326_b0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acscentsci.7b00252","article-title":"The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target","volume":"3","author":"Cromm","year":"2017","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0195","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ymthe.2019.09.025","article-title":"Ablation of Immunoproteasome \u03b25i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice","volume":"28","author":"Wang","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2022.115326_b0200","doi-asserted-by":"crossref","unstructured":"Y. Yang, W. Liu, D. Hu, R. Su, M. Ji, Y. Huang, A. Shereen Muhammad, X. Xu, Z. Luo, Q. Zhang, F. Liu, K. Wu, Y. Liu, J. Wu, M. Pizzato, R. Prasad Vinayaka, HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation, mBio 11(5) e02221-19.","DOI":"10.1128\/mBio.02221-19"},{"issue":"35","key":"10.1016\/j.bcp.2022.115326_b0205","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1002\/anie.201201616","article-title":"Inhibitors for the Immuno- and Constitutive Proteasome: Current and Future Trends in Drug Development","volume":"51","author":"Huber","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"issue":"22","key":"10.1016\/j.bcp.2022.115326_b0210","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.2174\/1381612811319220018","article-title":"Inhibitors of the Immunoproteasome: Current Status and Future Directions","volume":"19","author":"Miller","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdermsci.2009.02.007","article-title":"Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component","volume":"54","author":"Lin","year":"2009","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2022.115326_b0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bcp.2022.115326_b0225","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2022.115326_b0230","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115326_b0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41419-017-0194-1","article-title":"Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1\u03b2 production","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2022.115326_b0240","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"issue":"4 Suppl 92","key":"10.1016\/j.bcp.2022.115326_b0245","article-title":"The immunoproteasome: a novel drug target for autoimmune diseases","volume":"33","author":"Basler","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115326_b0250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/emmm.201303543","article-title":"Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis","volume":"6","author":"Basler","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2022.115326_b0255","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41590-018-0186-z","article-title":"The immunoproteasome and thymoproteasome: functions, evolution and human disease","volume":"19","author":"Murata","year":"2018","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/eji.201545578","article-title":"Inhibition and deficiency of the immunoproteasome subunit LMP7 attenuates LCMV-induced meningitis","volume":"46","author":"Mundt","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2022.115326_b0265","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.bcp.2022.115326_b0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2020.07.091","article-title":"LMP7 inhibits the activation of NLRP3 inflammasome through interaction with NLRP3","volume":"531","author":"Jin","year":"2020","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.bcp.2022.115326_b0275","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2018.01.011","article-title":"Upregulation of NLRP3 via STAT3-dependent histone acetylation contributes to painful neuropathy induced by bortezomib","volume":"302","author":"Liu","year":"2018","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41420-020-0245-8","article-title":"Metformin inhibits IL-1\u03b2 secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis","volume":"6","author":"Tsuji","year":"2020","journal-title":"Cell Death Discovery"},{"issue":"6","key":"10.1016\/j.bcp.2022.115326_b0285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"11\u20137082 inhibits the NF-\u03baB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clin. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2022.115326_b0290","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/molecules24112157","article-title":"Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7\/8\u2013MyD88\u2013NF-\u03baB\u2013NLRP3 Inflammasome Pathway","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2022.115326_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105682","article-title":"Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice","volume":"74","author":"Deng","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115326_b0300","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J, Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0305","doi-asserted-by":"crossref","first-page":"14674","DOI":"10.1038\/srep14674","article-title":"IL-1\u03b2 promotes Th17 differentiation by inducing alternative splicing of FOXP3","volume":"5","author":"Mailer","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2022.115326_b0310","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2020.12.010","article-title":"The TGF-\u03b2 superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2022.115326_b0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A Critical Role of the IL-1\u03b2\u2013IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J, Invest. Dermatol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:15:25Z","timestamp":1762096525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222004208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":63,"alternative-id":["S0006295222004208"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115326","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib inhibits NLRP3 inflammasome activation and NF-\u03baB pathway to reduce psoriatic inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115326"}}